GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes.
Saved in:
| Title: | GLIMSI: A real-world, multicenter study assessing the effectiveness and safety of Sitagliptin + Glimepiride + Metformin FDC in Indian patients with Type 2 diabetes. |
|---|---|
| Authors: | Zaveri, Kunal1 (AUTHOR), Kulkarni, Girish2 (AUTHOR) kulkarnigr99@gmail.com, Nair, Rathish2 (AUTHOR), Shanmugan, Govarthanan3 (AUTHOR), Dharmadhikari, Shubhada Amol4 (AUTHOR), Makkar, R. P. S.5 (AUTHOR), Jalgaonkar, Rahul6 (AUTHOR), Chatterjee, B. D.7 (AUTHOR), Korukonda, Krishnaprasad2 (AUTHOR) |
| Source: | PLoS ONE. 2/6/2026, Vol. 21 Issue 2, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0337107 |
